2m 2m 2m 2m 2m 2m 2m
CDT EQUITY (CDT)
NASDAQ
$1.01-$0.24 (-19.20%)
Price as of Oct 02, 2026 7:08 PM EDT- $17.1MMarket Cap
- -100.00%1-Year Change
- BiotechnologyIndustry
CDT EQUITY (CDT)
$1.01-$0.24 (-19.20%)
CDT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.25 | ||
Change | -$0.11 (-8.09%) | ||
Open | $1.34 | ||
High | $1.37 | ||
Low | $1.22 | ||
Previous Close | $1.36 | ||
Volume | 268,867 | ||
30-Day Average Volume | 403,848 | ||
1-Week Change | -58.68% | ||
1-Month Change | -96.62% | ||
1-Year Change | -100.00% | ||
3-Year Change | -100.00% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 13.7M | ||
Total Assets | $126.7M | ||
Market Cap | $17.1M | ||
Enterprise Value | $16.4M | ||
Period: QTR TTM FY | |||
Revenue | $341,000.00 | ||
Net Income | -$4.7M | ||
Free Cash Flow | -$544,000.00 | ||
EBIT | -$4.7M | ||
EBITDA | -$4.6M | ||
Net Working Capital | -$20.4M | ||
EPS | -$2,177.50 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | 48 | ||
P/B | N/A | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -31 | ||
Price/Operating Cash Flow | -31 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 09/29/2026 | ||
Earnings & Revenue